Literature DB >> 21807135

Echocardiographic evaluation of systolic and diastolic function in patients with cardiac amyloidosis.

Dan Liu1, Markus Niemann, Kai Hu, Sebastian Herrmann, Stefan Störk, Stefan Knop, Georg Ertl, Frank Weidemann.   

Abstract

The typical appearance of cardiac amyloidosis using standard echocardiographic techniques is usually a late finding only in patients with relatively advanced stages of the disease. Early noninvasive identification of cardiac amyloidosis is of growing clinical importance. Newer echocardiographic techniques, including tissue Doppler imaging and deformation imaging (strain rate imaging and 2-dimensional speckle tracking), are powerful tools for quantifying regional myocardial motion and deformation. Using these advanced techniques, early functional impairment in cardiac amyloidosis may be detectable when the results of standard echocardiography are still normal or inconclusive. This review provides a comprehensive overview of the different echocardiographic approaches for the assessment of systolic and diastolic function in patients with cardiac amyloidosis. Special attention is paid to regional myocardial function assessed by tissue Doppler imaging, strain rate imaging, and 2-dimensional speckle-tracking imaging.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21807135     DOI: 10.1016/j.amjcard.2011.03.092

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

1.  Impact of monitoring longitudinal systolic strain changes during serial echocardiography on outcome in patients with AL amyloidosis.

Authors:  Kai Hu; Dan Liu; Peter Nordbeck; Maja Cikes; Stefan Störk; Bastian Kramer; Philipp Daniel Gaudron; Andreas Schneider; Stefan Knop; Georg Ertl; Bart Bijnens; Frank Weidemann; Sebastian Herrmann
Journal:  Int J Cardiovasc Imaging       Date:  2015-07-16       Impact factor: 2.357

2.  Accurate analysis and visualization of cardiac (11)C-PIB uptake in amyloidosis with semiautomatic software.

Authors:  Tanja Kero; Lars Lindsjö; Jens Sörensen; Mark Lubberink
Journal:  J Nucl Cardiol       Date:  2015-07-15       Impact factor: 5.952

Review 3.  Cardiac Amyloidosis: Diagnosis and Treatment Strategies.

Authors:  Mirela Tuzovic; Eric H Yang; Arnold S Baas; Eugene C Depasquale; Mario C Deng; Daniel Cruz; Gabriel Vorobiof
Journal:  Curr Oncol Rep       Date:  2017-07       Impact factor: 5.075

4.  Subclinical left ventricular dysfunction in preeclamptic women with preserved left ventricular ejection fraction: a 2D speckle-tracking imaging study.

Authors:  Sajid Shahul; Julie Rhee; Michele R Hacker; Gaurav Gulati; John D Mitchell; Phil Hess; Feroze Mahmood; Zolt Arany; Sarosh Rana; Daniel Talmor
Journal:  Circ Cardiovasc Imaging       Date:  2012-08-13       Impact factor: 7.792

Review 5.  Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis.

Authors:  Mathew S Maurer; Perry Elliott; Raymond Comenzo; Marc Semigran; Claudio Rapezzi
Journal:  Circulation       Date:  2017-04-04       Impact factor: 29.690

Review 6.  [Epicardial fat: Imaging and implications for diseases of the cardiovascular system].

Authors:  M Niemann; H Alkadhi; A Gotschy; S Kozerke; R Manka
Journal:  Herz       Date:  2014-09-03       Impact factor: 1.443

7.  Transthyretin Cardiac Amyloidosis in Older Adults: Optimizing Cardiac Imaging to the Corresponding Diagnostic and Management Goal.

Authors:  Adam Castaño; Daniel K Manson; Mathew S Maurer; Sabahat Bokhari
Journal:  Curr Cardiovasc Risk Rep       Date:  2017-04-25

8.  Predictive value of assessing diastolic strain rate on survival in cardiac amyloidosis patients with preserved ejection fraction.

Authors:  Dan Liu; Kai Hu; Stefan Störk; Sebastian Herrmann; Bastian Kramer; Maja Cikes; Philipp Daniel Gaudron; Stefan Knop; Georg Ertl; Bart Bijnens; Frank Weidemann
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

9.  Predictors of cardiac involvement and survival in patients with primary systemic light-chain amyloidosis: roles of the clinical, chemical, and 3-D speckle tracking echocardiography parameters.

Authors:  Changhui Lei; Xiaoli Zhu; David H Hsi; Jing Wang; Lei Zuo; Shengjun Ta; Qianli Yang; Lei Xu; Xueli Zhao; Yan Wang; Shiren Sun; Liwen Liu
Journal:  BMC Cardiovasc Disord       Date:  2021-01-21       Impact factor: 2.298

10.  Cardiac amyloidosis and hypertrophic cardiomyopathy: A dangerous liaison.

Authors:  Elisa Ebrille; Paolo Di Donna; Stefano Leuzzi; Salvatore Miceli; Fiorenzo Gaita; Marco Scaglione
Journal:  Glob Cardiol Sci Pract       Date:  2013-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.